Table 1 Prospective studies showing that TyG index predicts incident metabolic syndrome
From: The role of the triglyceride-glucose index as a biomarker of cardio-metabolic syndromes
Son et al. | Kang et al. | D’Elia et al. | |
|---|---|---|---|
Year | 2022 | 2023 | 2024 |
Country | Korea | Korea | Italy |
Participants | N = 6091 | N = 3580 | N = 440 |
(40–69 yrs) | (40–70 yrs) | 50.3 yrs | |
50% Male | 47% Male | Male only | |
Follow up | 12 yrs | 14 yrs | 8 yrs |
New MetS diagnosis | 38.5% | 35.4% | 21.6% |
TyG Index: ROC-AUC | 0.65 (0.64–0.66) | 0.85 (0.84–0.87) | 0.69 (0.63–0.75) |
Other Comments | ROC-AUC for TyG index was significantly higher than HOMA-IR ,0.56 | ROC-AUC for TyG index was significantly higher than HOMA-IR ,0.70 | ROC-AUC for TyG index was not significantly different from HOMA-IR,0.62 |
5 SNPs were not additive to TyG index ROC-AUC |